Institutional Review Board (IRB) - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Institutional Review Board (IRB)

Description:

Institutional Review Board ... Historical Development of the IRB Nuremberg Code Declaration of Helsinki Belmont Report Respect for Persons Beneficence ... – PowerPoint PPT presentation

Number of Views:206
Avg rating:3.0/5.0
Slides: 15
Provided by: Techi157
Category:

less

Transcript and Presenter's Notes

Title: Institutional Review Board (IRB)


1
Institutional Review Board (IRB)
  • What is our Purpose and Role for
  • Ethical Research

2
Historical Development of the IRB
3
Nuremberg Code
  • War Crime Trials Standards
  • Voluntary consent/withdrawal at any time
  • Degree of risk not outweighed by human importance
  • Experimental design to protect
  • Termination of experiment at any stage if
    continuation is likely to result in injury,
    disability, or death

4
Declaration of Helsinki
  • Adopted June 1964
  • Biomedical Research to Improve
  • Diagnostic
  • Therapeutic and
  • Prophylactic procedures
  • Improve Understanding
  • Etiology and
  • Pathogenesis of disease

5
Belmont Report
  • Adopted April 18, 1979 ethical principles and
    guidelines for the protection of human subjects
  • Three basic (primary) ethical principles
  • Respect for persons (Autonomy)
  • Beneficiencetreated in an ethical manner
  • Justice

6
Respect for Persons
  • Persons should be treated as autonomous agents
  • persons with diminished autonomy are entitled to
    protection

7
Beneficence
  • Do no harm
  • Maximize possible benefits and minimize possible
    harms
  • sometimes research subjects are not direct
    beneficiaries

8
Justice
  • Developed from the Tuskegee syphilis studies of
    the 1940s, whereby rural black men were denied
    effective treatment to chart the untreated course
    of the disease even though it was not confined to
    that population
  • Who ought to receive the benefits of research and
    bear its burdens? Benefits and burdens of
    research to be distributed fairly
  • Mentally retarded children housed at the
    Willowbrook State School in Staten Island, New
    York, were intentionally given hepatitis in an
    attempt to track the development of the viral
    infection. The study began in 1956 and lasted for
    14 years. The researcher also wanted to determine
    the effectiveness of gamma globulin injections as
    protection against hepatitis.  They justified
    their deliberate infections and exposures by
    claiming that given that there was a high rate of
    infection in the institution it was practically
    inevitable that the children would become
    infected

9
Federal Regulations
  • HHS Title 45 CFR 46 The Protection of Human
    Subjects
  • Office of Human Research Protections (OHRP)
  • Common Rule
  • FDA Title 21 CFR 50, 54, 56, 312, 314
  • International Committee on Harmonisation (ICH)
    Guidelines
  • Good Clinical Practice

10
IRB Makeup
  • Minimum of 5 members
  • At least one community member
  • Varying backgrounds
  • Scientific and Non-scientific
  • Sufficiently qualified through experience and
    expertise
  • Meet the needs of studies reviewed
  • Must be nondiscriminatory

11
45 CFR 46.111Criteria for IRB Approval of
Research
  • (a) In order to approve research covered by this
    policy the IRB shall determine that all of the
    following requirements are satisfied
  • (1) Risks to subjects are minimized (i) By using
    procedures which are consistent with sound
    research design and which do not unnecessarily
    expose subjects to risk, and (ii) whenever
    appropriate, by using procedures already being
    performed on the subjects for diagnostic or
    treatment purposes.
  • (2) Risks to subjects are reasonable in relation
    to anticipated benefits, if any, to subjects, and
    the importance of the knowledge that may
    reasonably be expected to result. In evaluating
    risks and benefits, the IRB should consider only
    those risks and benefits that may result from the
    research (as distinguished from risks and
    benefits of therapies subjects would receive even
    if not participating in the research). The IRB
    should not consider possible long-range effects
    of applying knowledge gained in the research (for
    example, the possible effects of the research on
    public policy) as among those research risks that
    fall within the purview of its responsibility.

12
45 CFR 46.111Criteria for IRB Approval of
Research
  • (3) Selection of subjects is equitable. In making
    this assessment the IRB should take into account
    the purposes of the research and the setting in
    which the research will be conducted and should
    be particularly cognizant of the special problems
    of research involving vulnerable populations,
    such as children, prisoners, pregnant women,
    mentally disabled persons, or economically or
    educationally disadvantaged persons.
  • (4) Informed consent will be sought from each
    prospective subject or the subject's legally
    authorized representative, in accordance with,
    and to the extent required by 46.116.
  • (5) Informed consent will be appropriately
    documented, in accordance with, and to the extent
    required by 46.117.

13
45 CFR 46.111Criteria for IRB Approval of
Research
  • (6) When appropriate, the research plan makes
    adequate provision for monitoring the data
    collected to ensure the safety of subjects.
  • (7) When appropriate, there are adequate
    provisions to protect the privacy of subjects and
    to maintain the confidentiality of data.
  • (b) When some or all of the subjects are likely
    to be vulnerable to coercion or undue influence,
    such as children, prisoners, pregnant women,
    mentally disabled persons, or economically or
    educationally disadvantaged persons, additional
    safeguards have been included in the study to
    protect the rights and welfare of these subjects.

14
Questions?
Write a Comment
User Comments (0)
About PowerShow.com